International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden1. In clear cell renal cell carcinoma, obesity, hypertension and tobacco smoking are risk factors, but they do not explain the geographical variation in its incidence2. Underlying causes can be inferred by sequencing the genomes of cancers from populations with different incidence rates and detecting differences in patterns of somatic mutations. Here we sequenced 962 clear cell renal cell carcinomas from 11 countries with varying incidence. The somatic mutation profiles differed between countries. In Romania, Serbia and Thailand, mutational signatures characteristic of aristolochic acid compounds were present in most cases and but these were rare elsewhere. In Japan, a mutational signature of unknown cause was found in more than 70% of cases but in less than 2% elsewhere. A further mutational signature of unknown cause was ubiquitous but exhibited higher mutation loads in countries with higher incidence rates of kidney cancer. Known signatures of tobacco smoking correlated with tobacco consumption, but no signature was associated with obesity or hypertension, suggesting that non-mutagenic mechanisms of action underlie these risk factors. The results of this study indicate the existence of multiple, geographically variable, mutagenic exposures that potentially affect tens of millions of people and illustrate the opportunities for new insights into cancer causation through large-scale global cancer genomics.
Nature. 2024 May 01 [Epub ahead of print]
Sergey Senkin, Sarah Moody, Marcos Díaz-Gay, Behnoush Abedi-Ardekani, Thomas Cattiaux, Aida Ferreiro-Iglesias, Jingwei Wang, Stephen Fitzgerald, Mariya Kazachkova, Raviteja Vangara, Anh Phuong Le, Erik N Bergstrom, Azhar Khandekar, Burçak Otlu, Saamin Cheema, Calli Latimer, Emily Thomas, Joshua Ronald Atkins, Karl Smith-Byrne, Ricardo Cortez Cardoso Penha, Christine Carreira, Priscilia Chopard, Valérie Gaborieau, Pekka Keski-Rahkonen, David Jones, Jon W Teague, Sophie Ferlicot, Mojgan Asgari, Surasak Sangkhathat, Worapat Attawettayanon, Beata Świątkowska, Sonata Jarmalaite, Rasa Sabaliauskaite, Tatsuhiro Shibata, Akihiko Fukagawa, Dana Mates, Viorel Jinga, Stefan Rascu, Mirjana Mijuskovic, Slavisa Savic, Sasa Milosavljevic, John M S Bartlett, Monique Albert, Larry Phouthavongsy, Patricia Ashton-Prolla, Mariana R Botton, Brasil Silva Neto, Stephania Martins Bezerra, Maria Paula Curado, Stênio de Cássio Zequi, Rui Manuel Reis, Eliney Ferreira Faria, Nei Soares de Menezes, Renata Spagnoli Ferrari, Rosamonde E Banks, Naveen S Vasudev, David Zaridze, Anush Mukeriya, Oxana Shangina, Vsevolod Matveev, Lenka Foretova, Marie Navratilova, Ivana Holcatova, Anna Hornakova, Vladimir Janout, Mark P Purdue, Nathaniel Rothman, Stephen J Chanock, Per Magne Ueland, Mattias Johansson, James McKay, Ghislaine Scelo, Estelle Chanudet, Laura Humphreys, Ana Carolina de Carvalho, Sandra Perdomo, Ludmil B Alexandrov, Michael R Stratton, Paul Brennan
Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK., Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA., Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK., Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France., Service d'Anatomie Pathologique, Assistance Publique-Hôpitaux de Paris, Univeristé Paris-Saclay, Le Kremlin-Bicêtre, France., Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran., Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand., Division of Urology, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand., Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Łódź, Poland., Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania., Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan., Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan., Occupational Health and Toxicology Department, National Center for Environmental Risk Monitoring, National Institute of Public Health, Bucharest, Romania., Urology Department, Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania., Clinic of Nephrology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia., Department of Urology, University Hospital Dr D. Misovic Clinical Center, Belgrade, Serbia., International Organization for Cancer Prevention and Research, Belgrade, Serbia., Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Centre for Biodiversity Genomics, University of Guelph, Guelph, Ontario, Canada., Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Experimental Research Center, Genomic Medicine Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Transplant Immunology and Personalized Medicine Unit, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Service of Urology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil., Department of Anatomic Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil., Department of Epidemiology, A. C. Camargo Cancer Center, São Paulo, Brazil., Department of Urology, A. C. Camargo Cancer Center, São Paulo, Brazil., Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil., Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil., Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil., Department of Urology, Barretos Cancer Hospital, Barretos, Brazil., Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK., Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Department of Urology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia., Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Institute of Public Health and Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic., Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic., Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic., Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA., Bevital AS, Bergen, Norway., Observational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore., Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands., Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. .